{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:18:29Z","timestamp":1785161909124,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This work was supported by Shahrekord University of Medical Sciences, Shahrekord, Iran","award":["2141"],"award-info":[{"award-number":["2141"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12010-017-2684-0","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:59:11Z","timestamp":1519261151000},"page":"1132-1144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells"],"prefix":"10.1007","volume":"185","author":[{"given":"Zahre","family":"Sajadpoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Amini-Farsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-3290","authenticated-orcid":false,"given":"Hossein","family":"Teimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shamsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Sangtarash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Ghasemi-Dehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrokh","family":"Yadollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"2684_CR1","volume-title":"SEER Cancer Statistics Review, 1975\u20132012","author":"N Howlader","year":"2015","unstructured":"Howlader, N., Noone, A. M., Krapcho, M., Miller, D., Bishop, K., Altekruse, S. F., Kosary, C. L., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D. R., Chen, H. S., Feuer, E. J., & Cronin, K. A. (2015). SEER Cancer Statistics Review, 1975\u20132012. Bethesda: National Cancer Institute."},{"key":"2684_CR2","doi-asserted-by":"publisher","first-page":"26093","DOI":"10.1038\/srep26093","volume":"19","author":"ZG Zheng","year":"2016","unstructured":"Zheng, Z. G., Xu, H., Suo, S. S., Xu, X. L., Ni, M. W., Gu, L. H., Chen, W., Wang, L. Y., Zhao, Y., Tian, B., & Huab, Y. J. (2016). The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer. Sci Rep, 19, 26093.","journal-title":"Sci Rep"},{"key":"2684_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s12010-013-0561-z","volume":"172","author":"JL Zhao","year":"2014","unstructured":"Zhao, J. L., Zhao, J., & Jiao, H. J. (2014). Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. Appl Biochem Biotechnol, 172, 784\u2013791.","journal-title":"Appl Biochem Biotechnol"},{"key":"2684_CR4","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012). Molecular mechanisms of cisplatin resistance. Oncogene, 31, 1869\u20131883.","journal-title":"Oncogene"},{"key":"2684_CR5","doi-asserted-by":"crossref","unstructured":"Pan, J.J., Xie, X.J., Li, X., & Chen, W. (2015). Long non-coding RNAs and drug resistance Asian Pac J Cancer Prev, 16, 8067\u201373.","DOI":"10.7314\/APJCP.2015.16.18.8067"},{"key":"2684_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/365764a0","volume":"365","author":"Y Hao","year":"1993","unstructured":"Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., & Tycko, B. (1993). Tumour-suppressor activity of H19 RNA. Nature, 365, 764\u2013767.","journal-title":"Nature"},{"key":"2684_CR7","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1038\/sj.onc.1210266","volume":"26","author":"WP Tsang","year":"2007","unstructured":"Tsang, W. P., & Kwok, T. T. (2007). Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene, 26, 4877\u20134881.","journal-title":"Oncogene"},{"key":"2684_CR8","doi-asserted-by":"crossref","unstructured":"Matouk, I. J., Raveh, E., Abu-lail, R., Mezan, S., Gilon, M., Gershtain, E., Birman, T., Gallula, J., Schneider, T., Barkali, M., Richler, C., Fellig, Y., Sorin, V., Hubert, A., Hochberg, A., & Czerniak, A. (2014, 1843). Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta, 1414\u20131426.","DOI":"10.1016\/j.bbamcr.2014.03.023"},{"key":"2684_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2013.01.033","volume":"333","author":"M Luo","year":"2013","unstructured":"Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., & Qiu, J. (2013). Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett, 333, 213\u2013221.","journal-title":"Cancer Lett"},{"key":"2684_CR10","first-page":"913","volume":"473","author":"X Li","year":"2016","unstructured":"Li, X., Lin, Y., Yang, X., Wu, X., & He, X. (2016). Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. BBRC, 473, 913\u2013919.","journal-title":"BBRC"},{"key":"2684_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","volume":"46","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi, H., & Hung, M. C. (2014). Regulation and role of EZH2 in cancer. Cancer Res Treat, 46, 209\u2013222.","journal-title":"Cancer Res Treat"},{"key":"2684_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","volume":"9","author":"T Fan","year":"2011","unstructured":"Fan, T., Jiang, S., Chung, N., Alikhan, A., Ni, C., Lee, C. C., & Hornyak, T. J. (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression. Mol Cancer Res, 9, 418\u2013429.","journal-title":"Mol Cancer Res"},{"key":"2684_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bcj.2011.33","volume":"1","author":"C Nishioka","year":"2011","unstructured":"Nishioka, C., Ikezoe, T., Yang, J., Udaka, K., & Yokoyama, A. (2011). Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins. Blood Cancer J, 1, 1\u20139.","journal-title":"Blood Cancer J"},{"key":"2684_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00404-013-2762-7","volume":"288","author":"C Tsai","year":"2013","unstructured":"Tsai, C., Leslie, J. S., Franko-Tobin, L. G., Prasnal, M. C., Yang, T., Vienna Mackey, L., Fuselier, J. A., Coy, D. H., Liu, M., Yu, C., & Sun, L. (2013). Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II. Arch Gynecol Obstet, 288, 393\u2013400.","journal-title":"Arch Gynecol Obstet"},{"key":"2684_CR15","doi-asserted-by":"publisher","first-page":"35004","DOI":"10.18632\/oncotarget.5253","volume":"6","author":"D Thotala","year":"2015","unstructured":"Thotala, D., Karvas, R. M., Engelbach, J. A., Garbow, J. R., Hallahan, A. N., DeWees, T. A., Laszlo, A., & Hallahan, D. E. (2015). Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells. Oncotarget, 6, 35004\u201335022.","journal-title":"Oncotarget"},{"key":"2684_CR16","doi-asserted-by":"publisher","first-page":"e82895","DOI":"10.1371\/journal.pone.0082895","volume":"8","author":"Z Zhang","year":"2013","unstructured":"Zhang, Z., Convertini, P., Shen, M., Xu, X., Lemoine, F., Grange, P., Andres, D. A., & Stamm, S. (2013). Valproic acid causes proteasomal degradation of DICER and influences miRNA expression. PLOS ONE, 8, e82895.","journal-title":"PLOS ONE"},{"key":"2684_CR17","doi-asserted-by":"publisher","unstructured":"Dinesh, M., Deepika, S., HarishKumar, R., & Selvaraj, C. I. Evaluation of Octyl-\u03b2-D-Glucopyranoside (OGP) for cytotoxic, hemolytic, thrombolytic, and antibacterial activity. Appl Biochem Biotechnol. https:\/\/doi.org\/10.1007\/s12010-017-2661-7 .","DOI":"10.1007\/s12010-017-2661-7"},{"key":"2684_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2202-15-93","volume":"15","author":"MS Jami","year":"2014","unstructured":"Jami, M. S., Pal, R., Hoedt, E., Neubert, T. A., Larsen, J. P., & Moller, S. G. (2014). Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons. BMC Neurosci, 15, 93.","journal-title":"BMC Neurosci"},{"key":"2684_CR19","first-page":"146","volume":"25","author":"ZJ Jin","year":"2004","unstructured":"Jin, Z. J. (2004). About the evaluation of drug combination. Acta Pharmacol Sin, 25, 146\u2013147.","journal-title":"Acta Pharmacol Sin"},{"key":"2684_CR20","first-page":"20565","volume":"8","author":"E Liu","year":"2015","unstructured":"Liu, E., Liu, Z. H., Zhou, Y., Mi, R., & Wang, D. (2015). Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med, 8, 20565\u201320572.","journal-title":"Int J Clin Exp Med"},{"key":"2684_CR21","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1111\/j.1742-4658.2012.08694.x","volume":"279","author":"F Yang","year":"2012","unstructured":"Yang, F., Bi, J., Xue, X., Zheng, L., Zhi, K., Hua, J., & Fang, G. (2012). Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J, 279, 3159\u20133165.","journal-title":"FEBS J"},{"key":"2684_CR22","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.18632\/oncotarget.1913","volume":"5","author":"H Li","year":"2014","unstructured":"Li, H., Yu, B., Li, J., Su, L., Yan, M., Zhu, Z., & Liu, B. (2014). Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget, 5, 2318\u20132329.","journal-title":"Oncotarget"},{"key":"2684_CR23","first-page":"3501","volume":"9","author":"P Jiang","year":"2016","unstructured":"Jiang, P., Wang, P., Sun, X., Yuan, Z., Zhan, R., Ma, Z., & Li, W. (2016). Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco Targets Ther, 9, 3501\u20133509.","journal-title":"Onco Targets Ther"},{"key":"2684_CR24","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.18632\/oncotarget.13708","volume":"8","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Cheng, N., Li, X., Pan, H., Li, C., Ren, S. H., Su, C. H., Cai, W., Zhao, C. H., Zhang, L., & Zhou, C. (2017). Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget, 8, 2558\u20132567.","journal-title":"Oncotarget"},{"key":"2684_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00280-008-0747-1","volume":"63","author":"RB Erlich","year":"2009","unstructured":"Erlich, R. B., Rickwood, D., Coman, W. B., Saunders, N. A., & Guminski, A. (2009). Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas. Cancer Chemother Pharmacol, 63, 381\u2013389.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2684_CR26","unstructured":"Grabarska, A., Dmoszynska-Graniczka, M., Jeleniewicz, W., Kie\u0142bus, M., Nowosadzka, E., Rivero-Muller, A., Polberg, K., & Stepulak, A. (2014). Valproic acid suppresses growth and enhances cisplatin cytotoxicity to larynx cancer cells. Head Neck Oncol, 6, 1\u201311."},{"key":"2684_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4161\/cbt.6.2.3578","volume":"6","author":"A Valentini","year":"2007","unstructured":"Valentini, A., Gravina, P., Federici, G., & Bernardini, S. (2007). Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells. Cancer Biol Ther, 6, 185\u2013191.","journal-title":"Cancer Biol Ther"},{"key":"2684_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuint.2015.10.010","volume":"91","author":"H Oikawa","year":"2015","unstructured":"Oikawa, H., Goh, W. W., Lim, V. K., Wong, L., & Sng, J. C. (2015). Valproic acid mediates miR-124 to down-regulate a novel protein target, GNAI1. Neurochem Int, 91, 62\u201371.","journal-title":"Neurochem Int"},{"key":"2684_CR29","doi-asserted-by":"crossref","unstructured":"Oikawa, H., & Sng, J.C.G. (2016). Valproic acid as a microRNA modulator to promote neurite outgrowth, Neural Regen Res, 11, 1564\u201365.","DOI":"10.4103\/1673-5374.193227"},{"key":"2684_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dna.2016.3542","volume":"36","author":"Y Hao","year":"2017","unstructured":"Hao, Y., Wang, G., Lin, C. H., Li, D., Ji, Z. H., Gao, F., Li, Z., Liu, D., & Wang, D. (2017). Valproic acid induces decreased expression of H19 promoting cell apoptosis in A549 Cells. DNA Cell Biol, 36, 1\u20138.","journal-title":"DNA Cell Biol"},{"key":"2684_CR31","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.7314\/APJCP.2015.16.6.2425","volume":"16","author":"W Zhou","year":"2015","unstructured":"Zhou, W., Wang, J., Man, W. Y., Zhang, Q. W., & Xu, W. G. (2015). SiRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. Asian Pac J Cancer Prev, 16, 2425\u20132430.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2684_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1258\/ebm.2012.012075","volume":"237","author":"J Chen","year":"2012","unstructured":"Chen, J., Li, J., Han, Q., Sun, Z., Wang, J., Wang, S., & Zhao, R. C. (2012). Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia. Exp Biol Med, 237, 1110\u20131116.","journal-title":"Exp Biol Med"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-017-2684-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:20:38Z","timestamp":1603887638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-017-2684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1007\/s12010-017-2684-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}